Clinical trial
Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to…
NCT00290966 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00290966 |
|---|---|
| Title | Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer |
| Official title | Open Label, Randomized Multicentre Phase II/III Study of Docetaxel in Combination With Cisplatin (CDDP) or Docetaxel in Combination With 5-Fluorouracil (5-FU) and CDDP Compared to the Combination of CDDP and 5-FU in Patients With Metastatic or Locally Recurrent Gastric Cancer Previously Untreated… |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Stomach Neoplasm |
| Intervention type | Drug |
| Interventions | XRP6976 |
| Enrollment | 610 |
| Start date | Oct 1, 1998 |
| Completion | May 1, 2003 |
| First posted | Feb 13, 2006 |
| Last update posted | Apr 29, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: